Skip to main content
PMC home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 1994 May;3(5):737–749. doi: 10.1002/pro.5560030503

Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibody.

J F Schildbach 1, S Y Shaw 1, R E Bruccoleri 1, E Haber 1, L A Herzenberg 1, G C Jager 1, P D Jeffrey 1, D J Panka 1, D R Parks 1, R I Near 1, et al.
PMCID: PMC2142714  PMID: 8061604

Abstract

Two distinct spontaneous variants of the murine anti-digoxin hybridoma 26-10 were isolated by fluorescence-activated cell sorting for reduced affinity of surface antibody for antigen. Nucleotide and partial amino acid sequencing of the variant antibody variable regions revealed that 1 variant had a single amino acid substitution: Lys for Asn at heavy chain position 35. The second variant antibody had 2 heavy chain substitutions: Tyr for Asn at position 35, and Met for Arg at position 38. Mutagenesis experiments confirmed that the position 35 substitutions were solely responsible for the markedly reduced affinity of both variant antibodies. Several mutants with more conservative position 35 substitutions were engineered to ascertain the contribution of Asn 35 to the binding of digoxin to antibody 26-10. Replacement of Asn with Gln reduced affinity for digoxin 10-fold relative to the wild-type antibody, but maintained wild-type fine specificity for cardiac glycoside analogues. All other substitutions (Val, Thr, Leu, Ala, and Asp) reduced affinity by at least 90-fold and caused distinct shifts in fine specificity. The Ala mutant demonstrated greatly increased relative affinities for 16-acetylated haptens and haptens with a saturated lactone. The X-ray crystal structure of the 26-10 Fab in complex with digoxin (Jeffrey PD et al., 1993, Proc Natl Acad Sci USA 90:10310-10314) reveals that the position 35 Asn contacts hapten and forms hydrogen bonds with 2 other contact residues. The reductions in affinity of the position 35 mutants for digoxin are greater than expected based upon the small hapten contact area provided by the wild-type Asn. We therefore performed molecular modeling experiments which suggested that substitution of Gln or Asp can maintain these hydrogen bonds whereas the other substituted side chains cannot. The altered binding of the Asp mutant may be due to the introduction of a negative charge. The similarities in binding of the wild-type and Gln-mutant antibodies, however, suggest that these hydrogen bonds are important for maintaining the architecture of the binding site and therefore the affinity and specificity of this antibody. The Ala mutant eliminates the wild-type hydrogen bonding, and molecular modeling suggests that the reduced side-chain volume also provides space that can accommodate a congener with a 16-acetyl group or saturated lactone, accounting for the altered fine specificity of this antibody.

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alzari P. M., Spinelli S., Mariuzza R. A., Boulot G., Poljak R. J., Jarvis J. M., Milstein C. Three-dimensional structure determination of an anti-2-phenyloxazolone antibody: the role of somatic mutation and heavy/light chain pairing in the maturation of an immune response. EMBO J. 1990 Dec;9(12):3807–3814. doi: 10.1002/j.1460-2075.1990.tb07598.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arevalo J. H., Stura E. A., Taussig M. J., Wilson I. A. Three-dimensional structure of an anti-steroid Fab' and progesterone-Fab' complex. J Mol Biol. 1993 May 5;231(1):103–118. doi: 10.1006/jmbi.1993.1260. [DOI] [PubMed] [Google Scholar]
  3. Bentley G. A., Boulot G., Riottot M. M., Poljak R. J. Three-dimensional structure of an idiotope-anti-idiotope complex. Nature. 1990 Nov 15;348(6298):254–257. doi: 10.1038/348254a0. [DOI] [PubMed] [Google Scholar]
  4. Brauer A. W., Oman C. L., Margolies M. N. Use of o-phthalaldehyde to reduce background during automated Edman degradation. Anal Biochem. 1984 Feb;137(1):134–142. doi: 10.1016/0003-2697(84)90359-2. [DOI] [PubMed] [Google Scholar]
  5. Brünger A. T., Leahy D. J., Hynes T. R., Fox R. O. 2.9 A resolution structure of an anti-dinitrophenyl-spin-label monoclonal antibody Fab fragment with bound hapten. J Mol Biol. 1991 Sep 5;221(1):239–256. doi: 10.1016/0022-2836(91)80217-i. [DOI] [PubMed] [Google Scholar]
  6. Chothia C. Hydrophobic bonding and accessible surface area in proteins. Nature. 1974 Mar 22;248(446):338–339. doi: 10.1038/248338a0. [DOI] [PubMed] [Google Scholar]
  7. Cygler M., Rose D. R., Bundle D. R. Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. Science. 1991 Jul 26;253(5018):442–445. doi: 10.1126/science.1713710. [DOI] [PubMed] [Google Scholar]
  8. Diamond B., Scharff M. D. Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity. Proc Natl Acad Sci U S A. 1984 Sep;81(18):5841–5844. doi: 10.1073/pnas.81.18.5841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Eriksson A. E., Baase W. A., Zhang X. J., Heinz D. W., Blaber M., Baldwin E. P., Matthews B. W. Response of a protein structure to cavity-creating mutations and its relation to the hydrophobic effect. Science. 1992 Jan 10;255(5041):178–183. doi: 10.1126/science.1553543. [DOI] [PubMed] [Google Scholar]
  10. Fischmann T. O., Bentley G. A., Bhat T. N., Boulot G., Mariuzza R. A., Phillips S. E., Tello D., Poljak R. J. Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5-A resolution. J Biol Chem. 1991 Jul 15;266(20):12915–12920. [PubMed] [Google Scholar]
  11. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Glockshuber R., Stadlmüller J., Plückthun A. Mapping and modification of an antibody hapten binding site: a site-directed mutagenesis study of McPC603. Biochemistry. 1991 Mar 26;30(12):3049–3054. doi: 10.1021/bi00226a010. [DOI] [PubMed] [Google Scholar]
  13. Go K. T., Bhandary K. K. Structural studies on the biosides of Digitalis lanata: bisdigitoxosides of digitoxigenin, gitoxigenin and digoxigenin. Acta Crystallogr B. 1989 Jun 1;45(Pt 3):306–312. doi: 10.1107/s0108768189001734. [DOI] [PubMed] [Google Scholar]
  14. Herron J. N., He X. M., Mason M. L., Voss E. W., Jr, Edmundson A. B. Three-dimensional structure of a fluorescein-Fab complex crystallized in 2-methyl-2,4-pentanediol. Proteins. 1989;5(4):271–280. doi: 10.1002/prot.340050404. [DOI] [PubMed] [Google Scholar]
  15. Hudson N. W., Mudgett-Hunter M., Panka D. J., Margolies M. N. Immunoglobulin chain recombination among antidigoxin antibodies by hybridoma-hybridoma fusion. J Immunol. 1987 Oct 15;139(8):2715–2723. [PubMed] [Google Scholar]
  16. Hunter M. M., Margolies M. N., Ju A., Haber E. High-affinity monoclonal antibodies to the cardiac glycoside, digoxin. J Immunol. 1982 Sep;129(3):1165–1172. [PubMed] [Google Scholar]
  17. Jackson S. E., Moracci M., elMasry N., Johnson C. M., Fersht A. R. Effect of cavity-creating mutations in the hydrophobic core of chymotrypsin inhibitor 2. Biochemistry. 1993 Oct 26;32(42):11259–11269. doi: 10.1021/bi00093a001. [DOI] [PubMed] [Google Scholar]
  18. Jeffrey P. D., Strong R. K., Sieker L. C., Chang C. Y., Campbell R. L., Petsko G. A., Haber E., Margolies M. N., Sheriff S. 26-10 Fab-digoxin complex: affinity and specificity due to surface complementarity. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10310–10314. doi: 10.1073/pnas.90.21.10310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Komine S., Yoshida K., Yamashita H., Masaki Z. Voiding dysfunction in patients with human T-lymphotropic virus type-1-associated myelopathy (HAM). Paraplegia. 1989 Jun;27(3):217–221. doi: 10.1038/sc.1989.32. [DOI] [PubMed] [Google Scholar]
  20. Kunkel T. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A. 1985 Jan;82(2):488–492. doi: 10.1073/pnas.82.2.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kussie P. H., Parhami-Seren B., Wysocki L. J., Margolies M. N. A single engineered amino acid substitution changes antibody fine specificity. J Immunol. 1994 Jan 1;152(1):146–152. [PubMed] [Google Scholar]
  22. Near R. I., Ng S. C., Mudgett-Hunter M., Hudson N. W., Margolies M. N., Seidman J. G., Haber E., Jacobson M. A. Heavy and light chain contributions to antigen binding in an anti-digoxin chain recombinant antibody produced by transfection of cloned anti-digoxin antibody genes. Mol Immunol. 1990 Sep;27(9):901–909. doi: 10.1016/0161-5890(90)90157-u. [DOI] [PubMed] [Google Scholar]
  23. Novotny J., Bruccoleri R. E., Saul F. A. On the attribution of binding energy in antigen-antibody complexes McPC 603, D1.3, and HyHEL-5. Biochemistry. 1989 May 30;28(11):4735–4749. doi: 10.1021/bi00437a034. [DOI] [PubMed] [Google Scholar]
  24. Novotnỳ J., Margolies M. N. Amino acid sequence of the light chain variable region from a mouse anti-digoxin hybridoma antibody. Biochemistry. 1983 Mar 1;22(5):1153–1158. doi: 10.1021/bi00274a025. [DOI] [PubMed] [Google Scholar]
  25. Padlan E. A. On the nature of antibody combining sites: unusual structural features that may confer on these sites an enhanced capacity for binding ligands. Proteins. 1990;7(2):112–124. doi: 10.1002/prot.340070203. [DOI] [PubMed] [Google Scholar]
  26. Panka D. J., Margolies M. N. Complete variable region sequences of five homologous high affinity anti-digoxin antibodies. J Immunol. 1987 Oct 1;139(7):2385–2391. [PubMed] [Google Scholar]
  27. Panka D. J., Mudgett-Hunter M., Parks D. R., Peterson L. L., Herzenberg L. A., Haber E., Margolies M. N. Variable region framework differences result in decreased or increased affinity of variant anti-digoxin antibodies. Proc Natl Acad Sci U S A. 1988 May;85(9):3080–3084. doi: 10.1073/pnas.85.9.3080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Parhami-Seren B., Kussie P. H., Strong R. K., Margolies M. N. Conservation of binding site geometry among p-azophenylarsonate-specific antibodies. J Immunol. 1993 Mar 1;150(5):1829–1837. [PubMed] [Google Scholar]
  29. Rini J. M., Schulze-Gahmen U., Wilson I. A. Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science. 1992 Feb 21;255(5047):959–965. doi: 10.1126/science.1546293. [DOI] [PubMed] [Google Scholar]
  30. Rose D. R., Przybylska M., To R. J., Kayden C. S., Oomen R. P., Vorberg E., Young N. M., Bundle D. R. Crystal structure to 2.45 A resolution of a monoclonal Fab specific for the Brucella A cell wall polysaccharide antigen. Protein Sci. 1993 Jul;2(7):1106–1113. doi: 10.1002/pro.5560020705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Rudikoff S., Giusti A. M., Cook W. D., Scharff M. D. Single amino acid substitution altering antigen-binding specificity. Proc Natl Acad Sci U S A. 1982 Mar;79(6):1979–1983. doi: 10.1073/pnas.79.6.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Schildbach J. F., Near R. I., Bruccoleri R. E., Haber E., Jeffrey P. D., Ng S. C., Novotny J., Sheriff S., Margolies M. N. Heavy chain position 50 is a determinant of affinity and specificity for the anti-digoxin antibody 26-10. J Biol Chem. 1993 Oct 15;268(29):21739–21747. [PubMed] [Google Scholar]
  33. Schildbach J. F., Panka D. J., Parks D. R., Jager G. C., Novotny J., Herzenberg L. A., Mudgett-Hunter M., Bruccoleri R. E., Haber E., Margolies M. N. Altered hapten recognition by two anti-digoxin hybridoma variants due to variable region point mutations. J Biol Chem. 1991 Mar 5;266(7):4640–4647. [PubMed] [Google Scholar]
  34. Schillbach J. F., Near R. I., Bruccoleri R. E., Haber E., Jeffrey P. D., Novotny J., Sheriff S., Margolies M. N. Modulation of antibody affinity by a non-contact residue. Protein Sci. 1993 Feb;2(2):206–214. doi: 10.1002/pro.5560020209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Smith J. A., Margolies M. N. Complete amino acid sequence of the heavy-chain variable region from an A/J mouse antigen-nonbinding monoclonal antibody bearing the predominant arsonate idiotype. Biochemistry. 1984 Sep 25;23(20):4726–4732. doi: 10.1021/bi00315a031. [DOI] [PubMed] [Google Scholar]
  36. Smith J. A., Margolies M. N. Complete amino acid sequences of the heavy and light chain variable regions from two A/J mouse antigen nonbinding monoclonal antibodies bearing the predominant p-azophenyl arsonate idiotype. Biochemistry. 1987 Jan 27;26(2):604–612. doi: 10.1021/bi00376a036. [DOI] [PubMed] [Google Scholar]
  37. Sompuram S. R., Sharon J. Verification of a model of a F(ab) complex with phenylarsonate by oligonucleotide-directed mutagenesis. J Immunol. 1993 Mar 1;150(5):1822–1828. [PubMed] [Google Scholar]
  38. Stanfield R. L., Fieser T. M., Lerner R. A., Wilson I. A. Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 A. Science. 1990 May 11;248(4956):712–719. doi: 10.1126/science.2333521. [DOI] [PubMed] [Google Scholar]
  39. Strong R. K., Campbell R., Rose D. R., Petsko G. A., Sharon J., Margolies M. N. Three-dimensional structure of murine anti-p-azophenylarsonate Fab 36-71. 1. X-ray crystallography, site-directed mutagenesis, and modeling of the complex with hapten. Biochemistry. 1991 Apr 16;30(15):3739–3748. doi: 10.1021/bi00229a022. [DOI] [PubMed] [Google Scholar]
  40. Tulip W. R., Varghese J. N., Laver W. G., Webster R. G., Colman P. M. Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex. J Mol Biol. 1992 Sep 5;227(1):122–148. doi: 10.1016/0022-2836(92)90687-f. [DOI] [PubMed] [Google Scholar]
  41. Vix O., Rees B., Thierry J. C., Altschuh D. Crystallographic analysis of the interaction between cyclosporin A and the Fab fragment of a monoclonal antibody. Proteins. 1993 Apr;15(4):339–348. doi: 10.1002/prot.340150402. [DOI] [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES